Rabiasz GJ - Search Results

1

OPCML at 11q25 is epigenetically inactivated and has tumor-suppressor function in epithelial ovarian cancer.

Sellar GC, Watt KP, Rabiasz GJ, Stronach EA, Li L, Miller EP, Massie CE, Miller J, Contreras-Moreira B, Scott D, Brown I, Williams AR, Bates PA, Smyth JF, Gabra H. Sellar GC, et al. Among authors: rabiasz gj. Nat Genet. 2003 Jul;34(3):337-43. doi: 10.1038/ng1183. Nat Genet. 2003. PMID: 12819783

2

The homeobox gene BARX2 can modulate cisplatin sensitivity in human epithelial ovarian cancer.

Sellar GC, Watt KP, Li L, Nelkin BD, Rabiasz GJ, Porteous DJ, Smyth JF, Gabra H. Sellar GC, et al. Among authors: rabiasz gj. Int J Oncol. 2002 Nov;21(5):929-33. Int J Oncol. 2002. PMID: 12370737

3

Identification of clinically relevant genes on chromosome 11 in a functional model of ovarian cancer tumor suppression.

Stronach EA, Sellar GC, Blenkiron C, Rabiasz GJ, Taylor KJ, Miller EP, Massie CE, Al-Nafussi A, Smyth JF, Porteous DJ, Gabra H. Stronach EA, et al. Among authors: rabiasz gj. Cancer Res. 2003 Dec 15;63(24):8648-55. Cancer Res. 2003. PMID: 14695176

4

BARX2 induces cadherin 6 expression and is a functional suppressor of ovarian cancer progression.

Sellar GC, Li L, Watt KP, Nelkin BD, Rabiasz GJ, Stronach EA, Miller EP, Porteous DJ, Smyth JF, Gabra H. Sellar GC, et al. Among authors: rabiasz gj. Cancer Res. 2001 Oct 1;61(19):6977-81. Cancer Res. 2001. PMID: 11585719

5

Identification of a region of frequent loss of heterozygosity at 11q24 in colorectal cancer.

Connolly KC, Gabra H, Millwater CJ, Taylor KJ, Rabiasz GJ, Watson JE, Smyth JF, Wyllie AH, Jodrell DI. Connolly KC, et al. Among authors: rabiasz gj. Cancer Res. 1999 Jun 15;59(12):2806-9. Cancer Res. 1999. PMID: 10383136

6

Altered ErbB receptor signaling and gene expression in cisplatin-resistant ovarian cancer.

Macleod K, Mullen P, Sewell J, Rabiasz G, Lawrie S, Miller E, Smyth JF, Langdon SP. Macleod K, et al. Cancer Res. 2005 Aug 1;65(15):6789-800. doi: 10.1158/0008-5472.CAN-04-2684. Cancer Res. 2005. PMID: 16061661

7

Identification and characterization of a homozygous deletion found in ovarian ascites by representational difference analysis.

Watson JE, Gabra H, Taylor KJ, Rabiasz GJ, Morrison H, Perry P, Smyth JF, Porteous DJ. Watson JE, et al. Among authors: rabiasz gj. Genome Res. 1999 Mar;9(3):226-33. Genome Res. 1999. PMID: 10077528 Free article.

8

Transforming growth factor-beta mRNA expression and growth control of human ovarian carcinoma cells.

Bartlett JM, Rabiasz GJ, Scott WN, Langdon SP, Smyth JF, Miller WR. Bartlett JM, et al. Among authors: rabiasz gj. Br J Cancer. 1992 May;65(5):655-60. doi: 10.1038/bjc.1992.140. Br J Cancer. 1992. PMID: 1586592 Free PMC article.

9

Expression of the heat shock protein HSP27 in human ovarian cancer.

Langdon SP, Rabiasz GJ, Hirst GL, King RJ, Hawkins RA, Smyth JF, Miller WR. Langdon SP, et al. Among authors: rabiasz gj. Clin Cancer Res. 1995 Dec;1(12):1603-9. Clin Cancer Res. 1995. PMID: 9815962

10

Inhibition of transforming growth factor alpha (TGF-alpha)-mediated growth effects in ovarian cancer cell lines by a tyrosine kinase inhibitor ZM 252868.

Simpson BJ, Bartlett JM, Macleod KG, Rabiasz G, Miller EP, Rae AL, Gordge P, Leake RE, Miller WR, Smyth J, Langdon SP. Simpson BJ, et al. Br J Cancer. 1999 Mar;79(7-8):1098-103. doi: 10.1038/sj.bjc.6690175. Br J Cancer. 1999. PMID: 10098742 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

18 results

Search Page

Filters